2325 V (Benztropine 0.5 mg)
Pill imprint 2325 V has been identified as Benztropine mesylate 0.5 mg.
Benztropine is used in the treatment of extrapyramidal reaction; parkinson's disease; hyperhidrosis and belongs to the drug class anticholinergic antiparkinson agents. FDA has not classified the drug for risk during pregnancy. Benztropine 0.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 2325 V (Benztropine 0.5 mg)
- 0.5 mg
- 6.00 mm
- Prescription only
- Drug Class:
- Anticholinergic antiparkinson agents
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- N - Not a controlled drug
- Qualitest Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- croscarmellose sodium
calcium phosphate dibasic anhydrous
|NDC Code||Manufacturer / Repackager|
|51079-0404||UDL Laboratories Inc|
|68084-0381||Amerisource Health Services|
Note: Inactive ingredients may vary.
More about benztropine
- Benztropine tablets
- Benztropine (Advanced Reading)
- Benztropine Injection (Advanced Reading)
- Other brands: Cogentin